Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

radiopharmacy laboratory ltd. - exametazime 500 µg - kit for radiopharmaceutical preparation - 0,5 mg - exametazime 500 µg - technetium (99mtc) exametazime; v09ha02 technetium (99mtc) exametazime labelled cells

United Kingdom - English - myHealthbox

radiopharmacy laboratory ltd - human serum albumin nano sized colloid - kit for radiopharmaceutical preparation - 500micrograms - technetium (99mtc), particles and colloids - this medicinal product is for diagnostic use only. after radiolabelling with sodium (99mtc) pertechnetate solution for injection the solution obtained is indicated in: • bone marrow scanning (the product is not suitable to study the haematopoietic activity of the bone marrow) • inflammation scanning in areas other than the abdomen • conventional lymphoscintigraphy to demonstrate integrity of the lymphatic system and differentiation of venous from lymphatic obstruction • sentinel node detection in: • melanoma malignum • breast cancer

Australia - English - Department of Health (Therapeutic Goods Administration)

royal adelaide hospital radiopharmacy - antimony trisulfide, quantity: 1.1 mg/ml - injection, solution - excipient ingredients: water for injections; monobasic sodium phosphate dihydrate; dibasic sodium phosphate - technetium [99mtc] colloidal antimony sulphide injection is used for visualisation of lymphatic drainage following intradermal administration in the following conditions: lymphoedema, primary melanoma and breast carcinoma.

United States - English - NLM (National Library of Medicine)

wisconsin medical radiopharmacy, llc - ammonia n-13 (unii: 9oqo0e343z) (ammonia n-13 - unii:9oqo0e343z) - ammonia n 13 injection is indicated for diagnostic positron emission tomography (pet) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease. none animal reproduction studies have not been conducted with ammonia n 13 injection. it is also not known whether ammonia n 13 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. ammonia n 13 injection should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk and because of the potential for radiation exposure to nursing infants from ammonia n 13 injection, use alternative infant nutrition sources (e.g. stored breast milk or infant formula) for 2 hours (>10 half-lives of radioactive decay for n 13 isotope) after administration of the drug or avoid use of the drug, taking into account the importance

European Union - English - EMA (European Medicines Agency)

i.d.b. radiopharmacy b.v. - lutetium (177lu) chloride - radionuclide imaging - therapeutic radiopharmaceuticals - lumark is a radiopharmaceutical precursor. it is not intended for direct use in patients. this medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.

United States - English - NLM (National Library of Medicine)

wisconsin medical radiopharmacy, llc - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f 18 injection is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none risk summary data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data ). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose

Australia - English - Department of Health (Therapeutic Goods Administration)

royal adelaide hospital radiopharmacy - antimony trisulfide -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

radiopharmacy laboratory ltd. - albumin nanocolloid particles 0,5 mg - kit for radiopharmaceutical preparation - 0,5 mg - albumin human, nanocolloid particles 0.5 mg - technetium (99mtc) nanocolloid

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

institute of isotopes co. ltd. konkoly thege miklos str.29-33 - 131i sodium iodide - capsules hard - 0.5-37mbq

Malta - English - Medicines Authority

institute of isotopes co. ltd h-1121 budapest, konkoly-thege miklós út 29-33, hungary - tetrakis, methoxy isobutyl, isonitrile, copper, tetrafluorolborate - kit for radiopharmaceutical preparation powder for solution for injection - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate 1 mg - diagnostic radiopharmaceuticals